| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.4 | 9e-09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |